NEW YORK (360Dx) – Over the next year and a half, Bio-Rad Laboratories plans to add new solutions to bolster its burgeoning blood typing business. 

Over the past year and a half, Bio-Rad Laboratories has obtained US Food and Drug Administration clearance for new instruments targeting the US immunohematology blood typing market. During the next 18 months, the firm plans to round out its suite of with two additional instruments to meet different user needs, a company official said.